Literature DB >> 15142487

SARS in the Intensive Care Unit.

Gavin M. Joynt1, H. Y. Yap.   

Abstract

Approximately 20% of patients with severe acute respiratory syndrome (SARS) develop respiratory failure that requires admission to an intensive care unit (ICU). Old age, comorbidity, and elevated lactate dehydrogenase on hospital admission are associated with increased risk for ICU admission. ICU admission usually is late and occurs 8 to 10 days after symptom onset. Acute respiratory distress syndrome occurs in almost all admitted patients and most require mechanical ventilation. ICU admission is associated with significant morbidity, particularly an apparent increase in the incidence of barotrauma and nosocomial sepsis. Long-term mortality for patients admitted to the ICU ranges from 30% to 50%. Many procedures in ICUs pose a high risk for transmission of SARS coronavirus to health care workers. Contact and airborne infection isolation precautions, in addition to standard precautions, should be applied when caring for patients with SARS. Ensuring staff safety is important to maintain staff morale and delivery of adequate services.

Entities:  

Year:  2004        PMID: 15142487      PMCID: PMC7089324          DOI: 10.1007/s11908-004-0013-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  44 in total

Review 1.  Glucocorticoids and acute lung injury.

Authors:  B Taylor Thompson
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

2.  Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes.

Authors:  Peter Q Eichacker; Eric P Gerstenberger; Steven M Banks; Xizhong Cui; Charles Natanson
Journal:  Am J Respir Crit Care Med       Date:  2002-08-28       Impact factor: 21.405

3.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

Review 4.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

5.  Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee.

Authors:  J S Garner
Journal:  Infect Control Hosp Epidemiol       Date:  1996-01       Impact factor: 3.254

Review 6.  Effects of prone position ventilation in ARDS. An evidence-based review of the literature.

Authors:  Nicholas S Ward
Journal:  Crit Care Clin       Date:  2002-01       Impact factor: 3.598

7.  One-year outcomes in survivors of the acute respiratory distress syndrome.

Authors:  Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

8.  Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.

Authors:  Thomas W K Lew; Tong-Kiat Kwek; Dessmon Tai; Arul Earnest; Shi Loo; Kulgit Singh; Kim Meng Kwan; Yeow Chan; Chik Foo Yim; Siam Lee Bek; Ai Ching Kor; Wee See Yap; Y Rubuen Chelliah; Yeow Choy Lai; Soon-Keng Goh
Journal:  JAMA       Date:  2003-07-16       Impact factor: 56.272

9.  Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.

Authors:  K S Chan; S T Lai; C M Chu; E Tsui; C Y Tam; M M L Wong; M W Tse; T L Que; J S M Peiris; J Sung; V C W Wong; K Y Yuen
Journal:  Hong Kong Med J       Date:  2003-12       Impact factor: 2.227

10.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.

Authors:  J S M Peiris; C M Chu; V C C Cheng; K S Chan; I F N Hung; L L M Poon; K I Law; B S F Tang; T Y W Hon; C S Chan; K H Chan; J S C Ng; B J Zheng; W L Ng; R W M Lai; Y Guan; K Y Yuen
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

View more
  9 in total

1.  Pandemic influenza: implications for preparation and delivery of critical care services.

Authors:  Mary-Elise Manuell; Mary Dawn T Co; Richard T Ellison
Journal:  J Intensive Care Med       Date:  2011-01-10       Impact factor: 3.510

Review 2.  Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV.

Authors:  Disha Panchal; Jeena Kataria; Kamiya Patel; Kaytlyn Crowe; Varun Pai; Abdul-Rahman Azizogli; Neil Kadian; Sreya Sanyal; Abhishek Roy; Joseph Dodd-O; Amanda M Acevedo-Jake; Vivek A Kumar
Journal:  Adv Ther (Weinh)       Date:  2021-08-06

3.  Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis.

Authors:  Semagn Mekonnen Abate; Siraj Ahmed Ali; Bahiru Mantfardo; Bivash Basu
Journal:  PLoS One       Date:  2020-07-10       Impact factor: 3.240

4.  Chapter 6. Protection of patients and staff during a pandemic. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.

Authors:  Bruce L Taylor; Hugh E Montgomery; Andrew Rhodes; Charles L Sprung
Journal:  Intensive Care Med       Date:  2010-04       Impact factor: 17.440

Review 5.  The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.

Authors:  Pedro F N Souza; Felipe P Mesquita; Jackson L Amaral; Patrícia G C Landim; Karollyny R P Lima; Marília B Costa; Izabelle R Farias; Luina B Lima; Raquel C Montenegro
Journal:  Int J Biol Macromol       Date:  2021-03-02       Impact factor: 8.025

Review 6.  Risk management and communication plans from SARS to COVID-19 and beyond.

Authors:  Virginia Recchia; Alessandra Aloisi; Antonella Zizza
Journal:  Int J Health Plann Manage       Date:  2022-08-19

7.  Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.

Authors:  Michael Har-Noy; Reuven Or
Journal:  J Transl Med       Date:  2020-05-12       Impact factor: 5.531

8.  The Clinical Features and Prognostic Assessment of SARS-CoV-2 Infection-Induced Sepsis Among COVID-19 Patients in Shenzhen, China.

Authors:  Chao Ren; Ren-Qi Yao; Di Ren; Jin-Xiu Li; Ying Li; Xue-Yan Liu; Lei Huang; Yong Liu; Mian Peng; Yao Yao; Yong-Wen Feng; Yong-Ming Yao
Journal:  Front Med (Lausanne)       Date:  2020-10-15

Review 9.  Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis.

Authors:  Semagn Mekonnen Abate; Yigrem Ali Checkol; Bahiru Mantefardo
Journal:  Ann Med Surg (Lond)       Date:  2021-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.